FR-295389 is a new cephalosporin. FR-295389 shows effective in vitro antibacterial activity against metallo-beta-lactamase (MBL)-producers. The MIC values of FR295389 at which 50% and 90% of 21 clinical isolates of IMP-type MBL-producing Pseudomonas aeruginosa were inhibited were 8.0 and 32 mug/ml, respectively. References: Takeda S, Ikeda F, Hatano K. In vitro antibacterial activity of a new cephalosporin, FR295389, against IMP-type metallo-beta-lactamase-producers. J Antibiot (Tokyo). 2008 Jan;61(1):36-9. doi: 10.1038/ja.2008.107. PubMed PMID: 18305358.

纯度：≥98%

CAS：1019207-72-7